Scott H Greenwald, PhD
Pierce Lab/Ocular Genomics Institute
Scott Greenwald graduated from the University of Pennsylvania with a degree in the biological basis of behavior before joining Second Sight Medical Products to research the perceptual effects of artificial retinal stimulation in patients with advanced retinitis pigmentosa. He went on to study cone photoreceptor dysfunction associated with inherited retinal diseases at the University of Washington where he earned a PhD in neurobiology.
Scott was a member of the Ocular Genomics Institute at MEEI from 2013 to 2019. He identified cellular mechanisms underlying NMNAT1-associated retinal degeneration and developed a gene therapy for this disease in a mouse model.
Research Areas: Retinal disease, cone photoreceptors, retinal prostheses, mouse models, gene therapy, molecular biology, human psychophysics